Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ApNano Materials is a nanotechnology company that pioneered the commercialization of inorganic fullerene-like tungsten disulfide (IF-WS2) nanoparticles, originally discovered at the Weizmann Institute of Science. The company's core technology, marketed under the brand NanoLub, provides advanced lubrication and coating solutions that significantly reduce friction and wear in mechanical systems. Within the life sciences sector, ApNano's materials are utilized to enhance the performance of medical devices, orthodontic wires, and dental tools by providing superior lubricity and biocompatibility. The company's proprietary manufacturing process allows for the production of these unique structures at an industrial scale. ApNano was later integrated into Nanotech Industrial Solutions (NIS), which continues to develop these nanomaterials for diverse industrial and medical applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ApNano Materials.